RTW Investments

Founded in 2009, RTW Investments is a global investment firm headquartered in New York with offices in London and Shanghai. It primarily focuses on the life sciences, big data, and digital health sectors across the United States, Europe, and beyond.

Ovid Amadi

Analyst

Josh Baldwin

Managing Director, Communications

James Bellush

Analyst

Lauren Cujé

Senior Associate

Peter Fong

Managing Director

Sean Haggerty

Principal

Joshua Kennedy-Smith

Managing Director

Lauren Lee

Research Analyst

Chris Liu

Analyst

Sabera Loughran

Partner

Gotham Makker

Partner, Head of Strategic Investments

Tony Nguyen

Managing Director and Research Analyst

Piratip Pratumsuwan

Managing Director

Stephanie Sirota

Partner

Sebastian Trousil

Principal

Roderick Wong MD

Managing Partner

Naveen Yalamanchi

Partner

Past deals in South Dakota

SAb Biotherapeutics

Post in 2023
SAB Biotherapeutics is a clinical-stage biopharmaceutical company established in 2014, headquartered in Sioux Falls, South Dakota with additional offices in Cambridge, Massachusetts. The company specializes in developing immunotherapies using its proprietary DiversitAb platform, which employs transchromosomic cattle to produce large quantities of targeted human polyclonal antibodies without relying on human plasma or serum. SAB's pipeline includes therapies for conditions such as Type 1 diabetes (SAB-142), seasonal influenza (SAB-176), and Middle East Respiratory Syndrome Coronavirus (MERS-CoV, SAB-301).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.